Andrew J Wood
Venture Partner @ Advent Life Sciences
Andrew J Wood is a startup investor at Advent Life Sciences. Andrew joined Advent in 2011 after 18 years of experience in the pharmaceutical industry with Eli Lilly & Co. At Lilly, he was initially responsible for clinical development and registration of new molecules, principally in relation to neurological and psychiatric disorders. He then managed both clinical and preclinical discovery organisations,across multiple therapeutic areas, in Europe and in Asia. Latterly, Andrew was leader of Eli Lilly’s in-licensing and business development organisation in Europe. Within this role, he had responsibility for evaluating drug and technology development projects and for structuring collaborations with external partners in the biotechnology sector and in academia.Andrew retired from Eli Lilly in February 2010, since when he has worked as an independent consultant to the pharmaceutical and biotech sectors.Andrew graduated in Natural Sciences from Cambridge University and in Clinical Medicine from the Oxford University Medical School, and spent 10 years in academic medicine before entering the pharmaceutical industry.Andrew has advised several Advent portfolio companies including NeRRe Therapeutics, and is currently a Director of Calcico.
Last updated:
For AI agents: llms.txt
About Advent Life Sciences
Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,
Advent Life Sciences Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Andrew J Wood
Venture Partner
|
|||
Dale Pfost
General Partner
|
|||
Kaasim Mahmood
General Partner
|
|||
Satish Jindal
General Partner
|
|||
Shahzad Malik
General Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
